EGF and cancer: Results obtained using reproductive and non-reproductive cells, untransformed cells (fibroblasts) or cells derived from different human cancers (prostate, breast, colon and pancreas) indicate that AR blockade by Casodex impairs EGF-elicited biological responses in these cells.